JOANNA WOLICKI-SHANNON: Open Payments
NPI 1245240969 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,993 in 183 payments from 15 companies in 2025. Trend: 2023 $2,119 · 2024 $1,945 · 2025 $2,993
Food & beverage: $2,784Education: $209
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 40 | $545 |
| E.R. Squibb & Sons, L.L.C. | 21 | $429 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $328 |
| ABBVIE INC. | 29 | $301 |
| Otsuka America Pharmaceutical, Inc. | 20 | $284 |
| Vanda Pharmaceuticals Inc. | 13 | $250 |
| Lundbeck LLC | 8 | $159 |
| Alkermes, Inc. | 10 | $156 |
| Neurocrine BioSciences, Inc. | 5 | $105 |
| Axsome Therapeutics, Inc. | 6 | $93 |
Products named: COBENFY, REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR, HETLIOZ, ARISTADA, INGREZZA.
Industry payments across NC — which companies pay providers there.
